Alpha Paradigm Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$146K Buy
1,896
+1,593
+526% +$121K 0.06% 345
2022
Q3
$20K Buy
+303
New +$19.2K 0.01% 431
2022
Q2
Sell
-2,799
Closed -$159K 512
2022
Q1
$159K Sell
2,799
-3,204
-53% -$172K 0.06% 379
2021
Q4
$309K Buy
6,003
+3,547
+144% +$174K 0.12% 268
2021
Q3
$121K Sell
2,456
-7,556
-75% -$410K 0.05% 406
2021
Q2
$572K Buy
+10,012
New +$585K 0.22% 167
2021
Q1
Sell
-13,335
Closed -$714K 509
2020
Q4
$714K Buy
+13,335
New +$692K 0.25% 105

Other funds holding CAH

Alpha Paradigm Partners's CAH Position: Q4 2022 in Review

Alpha Paradigm Partners increased its Cardinal Health (CAH) stake by 526% in Q4 2022, buying an estimated $121K and bringing the position to 1,896 shares worth $146K. The position accounts for 0.06% of the portfolio, ranked #345.

Alpha Paradigm Partners first reported a position in CAH in Q4 2020 and has held it in 7 quarters since. The position peaked at $714K in Q4 2020. 930 funds tracked by Wall St. Rank hold CAH as of Q4 2022.

  • Alpha Paradigm Partners held 1,896 shares of Cardinal Health worth $146K as of Q4 2022.
  • Alpha Paradigm Partners bought 1,593 Cardinal Health shares in Q4 2022, an estimated $121K.
  • Cardinal Health made up 0.06% of Alpha Paradigm Partners's portfolio in Q4 2022, its #345 holding.
  • Alpha Paradigm Partners first reported a position in Cardinal Health in Q4 2020 and has held it in 7 quarters since.
  • Alpha Paradigm Partners's Cardinal Health position peaked at $714K in Q4 2020.
  • 930 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.